Launching the first national program for SMA in Egypt

The Ministry of Health and Population Egypt and Biologix FzCo signed an agreement today as part of a presidential initiative to launch the first national program for the treatment of Spinal Muscular Atrophy (SMA) patients, in line with the vision of the new republic.

Positioned across 17+ key strategic locations in the Gulf Cooperation Council (GCC), Egypt, North Africa and the Levant, we at Biologix are pioneers in regional distribution and promotion of innovative products and solutions for difficult-to-treat diseases.